| 注册
首页|期刊导航|中国医药科学|基于KAP的福建移动互联网用户用药风险调查研究

基于KAP的福建移动互联网用户用药风险调查研究

周丽婷 丁珊 洪婉凤 施婷婷 方盈盈 姜维文

中国医药科学2025,Vol.15Issue(8):142-145,149,5.
中国医药科学2025,Vol.15Issue(8):142-145,149,5.DOI:10.20116/j.issn2095-0616.2025.08.31

基于KAP的福建移动互联网用户用药风险调查研究

KAP based survey on drug risk of Fujian mobile internet users

周丽婷 1丁珊 1洪婉凤 1施婷婷 1方盈盈 1姜维文2

作者信息

  • 1. 复旦大学附属中山医院厦门医院药剂科,福建厦门 361015
  • 2. 复旦大学附属中山医院药剂科,上海 200032
  • 折叠

摘要

Abstract

Objective To investigate the status quo of knowledge,attitude,practice(KAP)of Fujian mobile internet users(MIs)on medication behavior risk,analyze the risks and impacting factors in the course of medication of MIs,and provide a reference basis for science education on safe medication of MIs.Methods A cross-sectional study method and KAP model were used to conduct an electronic questionnaire survey on MIs aged 18 and above.The impact of MIs basic information on medication risk KAP was analyzed by one-way ANOVA.The impacting factors of KAP score were analyzed by binary logistic regression.Results A total of 554 valid questionnaires were collected.The average scores for KAP related to MIs average were(70.69±19.82),(29.20±8.50),and(54.86±9.14)points.MIs scored well in terms of KAP towards medication.The results of one-way ANOVA showed that there were statistically significant differences in KAP scores in MIs with different ages,education levels,occupations,and residences(P<0.05).The binary logistic regression results showed that education level,occupation,and place of residence were the main factors impacting the KAP score of MIs medication behavior risk.Conclusion The KAP score rate of medication behavior risk in Fujian MIs is good,and the risk of safe medication is relatively low.However,it is still necessary to carry out safety medication popularization for high-risk populations.

关键词

移动互联网用户/知信行理论/用药风险/安全用药

Key words

Mobile internet users/Theory of knowledge,attitude,practice/Medication risk/Safe medication

分类

医药卫生

引用本文复制引用

周丽婷,丁珊,洪婉凤,施婷婷,方盈盈,姜维文..基于KAP的福建移动互联网用户用药风险调查研究[J].中国医药科学,2025,15(8):142-145,149,5.

基金项目

中国药学会科技开发中心科普研究重点项目(CMEI2024KPYJ001228). (CMEI2024KPYJ001228)

中国医药科学

2095-0616

访问量0
|
下载量0
段落导航相关论文